These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36544782)

  • 1. Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma.
    Guo Q; Wu CY; Jiang N; Tong S; Wan JH; Xiao XY; Mei PY; Liu HS; Wang SH
    Front Immunol; 2022; 13():986447. PubMed ID: 36544782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.
    Wu R; Ma R; Duan X; Zhang J; Li K; Yu L; Zhang M; Liu P; Wang C
    Front Immunol; 2023; 14():1236444. PubMed ID: 37841237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analyses of a CD8
    Chen L; Weng Y; Cui X; Li Q; Peng M; Song Q
    BMC Bioinformatics; 2023 Jun; 24(1):238. PubMed ID: 37280525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
    Shan G; Minchao K; Jizhao W; Rui Z; Guangjian Z; Jin Z; Meihe L
    J Pharm Biomed Anal; 2023 May; 229():115346. PubMed ID: 37001272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of the Perturbation of PKIG in Lung Squamous Cell Carcinoma and the Role in Tumor Microenvironment Based on Bioinformatics Method].
    Liu Q; Li H; Li B; Ren M; Li Z; Chen Y; Zheng Z; Meng Y; Feng H
    Zhongguo Fei Ai Za Zhi; 2023 Jul; 26(7):523-537. PubMed ID: 37653016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HHIP-AS1 suppresses lung squamous cell carcinoma by stabilizing HHIP mRNA.
    Hu Z; Liu Y; Tang J; Luo R; Qin J; Mo Z; Xie J; Jiang X; Wei S; Lin C
    Life Sci; 2023 May; 321():121578. PubMed ID: 36958438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGN as a prognostic biomarker with immune infiltration and ceRNA in lung squamous cell carcinoma.
    Liao Y; Cheng W; Mou R; Li X; Jia Y
    Sci Rep; 2023 May; 13(1):7553. PubMed ID: 37161020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
    BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of the immune microenvironment associated with 12 cell death modes and construction of a prognostic model for squamous cell lung cancer.
    Bin Y; Ding P; Liu L; Tong F; Dong X
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9051-9070. PubMed ID: 37169931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma.
    Zhang W; Li GS; Gan XY; Huang ZG; He RQ; Huang H; Li DM; Tang YL; Tang D; Zou W; Liu J; Dang YW; Chen G; Zhou HF; Kong JL; Lu HP
    PeerJ; 2023; 11():e15598. PubMed ID: 37601247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.
    Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma.
    Mao G; Yang D; Liu B; Zhang Y; Ma S; Dai S; Wang G; Tang W; Lu H; Cai S; Zhu J; Yang H
    Respir Res; 2023 Jul; 24(1):176. PubMed ID: 37415224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived KLK8 predicts inferior survival and promotes an immune-suppressive tumor microenvironment in lung squamous cell carcinoma.
    Tian H; Wei R; Xiao C; Fan T; Che Y; Liu T; Zheng B; Li C; He J
    BMC Pulm Med; 2024 Jan; 24(1):53. PubMed ID: 38273291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
    Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
    PeerJ; 2023; 11():e16447. PubMed ID: 38084139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage.
    Du N; Zhang B; Zhang Y
    Can Respir J; 2023; 2023():4533504. PubMed ID: 37547297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a prognostic model toward lung squamous cell carcinoma based on m
    Wang Y; Liu Y; Wang R; Cao F; Guan Y; Chen Y; An B; Qin S; Yao S
    Physiol Genomics; 2023 Oct; 55(10):427-439. PubMed ID: 37575065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.
    Wang XJ; Chen JP; Qiao XW; Meng WY; Wang YW; Meng YC; Zhao R; Lin W; Liao YD; Xiao H; Mei PY
    Curr Med Sci; 2024 Apr; 44(2):309-327. PubMed ID: 38517673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.